General Information
Version
DRE-C13166950 - Enoxacin
Revision date
2025-09-04
Product name
Enoxacin
Substance name
C15H17FN4O3 320.32
CAS No.
74011-58-8
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC Limited
Emergency telephone
1-800-424-9300, +1 703-741-3877
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H334, H336
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Enoxacin
Signal word
Danger
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H336 - May cause drowsiness or dizziness.
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapors and spray P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves, eye protection and face protection P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P321 - Specific treatment (see supplemental first aid instructions on this label) P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention
2.3 Other hazards
No information available.
PBT Substances
& vPvB This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin irritation Category 2 - (H315) Eye irritation Category 2 - (H319) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Specific target organ toxicity (single exposure) Category 3 - (H336) Category 3 Target organ effects: Narcotic effects.
